Thursday, August 6, 2020

Remdesivir Priced At More Than $3,100 For A Course Of Treatment



When people will pay anything. 

Your money or your life? 

Let the market decide. 

In the United States, Gilead Sciences will charge $520 per vial for patients with private insurance, with some government programs getting a lower price. With a double-dose the first day, that comes out to $3,120 for the five-day treatment course. For governments in developed countries outside the U.S., it will cost $390 per vial, or $2,340 for the five-day course. How much uninsured patients would pay is still unclear.

Rep. Lloyd Doggett, D-Texas, called the price "outrageous."

"Without a taxpayer investment of $99 million, this drug would have been abandoned. It would be on the scrap heap of failures," he tells NPR. "So it's the taxpayer who's really taking the risk here and ought to get the reward of the angel investors that taxpayers are."

 Remdesivir, made by @GileadSciences, has now set the price ➡️ $2,300 to $3,100 per patient.
So how much does it cost to produce each vial? 
➡️ Just $1. 
US taxpayers also had paid for the drug’s NIH trial. 

NPR

Remdesivir Priced At More Than $3,100 For A Course Of Treatment-3-100-for-a-course-of-treatment

 

4 comments:

Matt Franko said...

“ So how much does it cost to produce each vial?
➡️ Just $1. ”

There is NO WAY IN HELL that is true....

Peter Pan said...

It won't be true if you keep publicizing that fact...

Matt Franko said...

Just transporting it from the manufacturing facility to the provider would cost multiples of that....

Kaivey said...

I got that figure from a doctor on twitter. He could be right, at least for manufacture.

Experts say even $10 may be too much for Gilead's remdesivir

Gilead has not revealed how much its antiviral drug, remdesivir, which is approved by the FDA to treat coronavirus, will cost

The California-based company drew intense public scrutiny when it priced its hepatitis C treatment at $1,000 per pill in 2013

A report estimated that it costs $9.32 to manufacture one 10-day course of remdesivir treatment 

The cost watchdog said that, if the drug is proven to save lives, Gilead could charge up to $4,500 per treatment

But consumer advocates say anything more than $10 does not constitute fair pricing during a pandemic

https://www.dailymail.co.uk/health/article-8298253/How-remdesivir-cost-Experts-say-10-Gileads-antiviral.html?ito=amp_twitter_share-top via @MailOnline